AlphAIAlphAI — Financial news for AI agents
stocktitan.net$PRGO

Perrigo shareholders will receive 29 cents per share on Dec. 15.

Perrigo Company plc (PRGO) announced a quarterly dividend of 29 cents per share, payable on December 15. The company is a provider of consumer self-care products and OTC health solutions. Payment is subject to board discretion and depends on earnings and financial conditions.

Original reporting
stocktitan.net
Published Oct 29, 2026, 4:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 4:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$PRGO
Neutral
high confidence
Mentioned
$PRGO
Relevance
6/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$PRGONeutralMed
01

Why it matters

The dividend announcement provides a clear, time‑sensitive catalyst for short‑term trading strategies focused on dividend capture.

02

Market read

A modest dividend adds a short‑term buying incentive but does not materially alter the company's longer‑term outlook.

03

What to watch

Potential tax implications for investors in high‑tax jurisdictions could dampen demand.

Relevance 6/10Novelty 7/10Timing: pre‑dividend capture before Dec. 15

Background

Perrigo Company plc, a consumer self‑care and OTC health products provider, issued a press release announcing its quarterly dividend.

Company-level read

Ticker impact

$PRGONeutralHigh confidence
Context

Perrigo announced a quarterly dividend of $0.29 per share payable on Dec. 15.

Expected impact

modest upside as dividend‑capture trades lift the stock

Evidence & confidence

The new dividend is a primary corporate action; such announcements typically generate short‑term demand from dividend‑seeking traders.

Market effects

Sector

May slightly improve sentiment for the consumer self‑care sector as dividend‑paying peers are viewed favorably.

Regional

Limited to U.S. investors; no broader regional effect.

Global

Minimal global impact beyond Perrigo shareholders.

Counterpoint

What could challenge this read

Dividend may signal limited growth prospects, prompting some investors to stay away.

Key entities

  • company
    Perrigo Company plc

    Issuer of the announced dividend.

Read at source← All news

Related articles

$PRGOMed

Perrigo Q3 Earnings Call Highlights

Perrigo (PRGO) reported Q3 earnings with net sales declines in self-care and specialty care segments. Adjusted EPS fell to 61 cents, with a lower tax rate providing some benefit. The company expects 2026 sales declines and adjusted EPS of $2.15-$2.35. Perrigo is divesting infant formula and other businesses to simplify operations and reduce debt. Cash and debt at quarter-end were $437M and $3.3B, respectively.

finance.yahoo.com
$PRGOHigh

Perrigo Sets 2026 All-In Adjusted EPS Outlook at $2.25 to $2.45

Perrigo Company plc set its 2026 adjusted diluted EPS outlook at $2.25 to $2.45, excluding its infant formula unit, which it classified as discontinued operations. Core EPS is expected at $2.15 to $2.35, with core sales declining 2.5% to 3.6% and an adjusted operating margin of 14% to 15%. The company plans to sell the unit to MeridianMade for up to $175 million, with $40 million upfront.

tokenpost.com
$PRGOMed

Perrigo Co PLC (PRGO) (Q3 2026) Earnings Call Highlights: Margin Gains and Share Growth

Perrigo (PRGO) reported Q3 2026 core net sales declined 1.7% YoY, with organic sales down 1.1%. Adjusted gross margin fell 140 bps to 37.9%. The company updated its 2026 outlook downward, citing retailer inventory positioning and European softness. Interim CEO Albert Manzone highlighted share gains, innovation, and e-commerce growth as priorities. The infant formula divestiture is complete, and oral care is under strategic review.

finance.yahoo.com
$PRGOMed

Perrigo (PRGO) Q3 2026 Earnings Call Transcript

Perrigo (PRGO) reported Q3 2026 earnings, highlighting operational improvements and a strategic focus on simplifying the business. The company saw sequential improvements in core net sales and operating margins, with a 1.7% decline in sales and a 14.3% operating margin. Perrigo announced the sale of its infant formula business and updated its 2026 outlook, reflecting divestments and market conditions.

finance.yahoo.com
$PRGOMed

Perrigo Company plc Q3 2026 Earnings Call Summary

Perrigo reported Q3 2026 improvements in core adjusted operating margins (12.8% to 14.3%) due to its Three-S plan. The company is simplifying its portfolio, including divesting the infant formula business, to focus on higher-margin categories. Market share gains in U.S. and European OTC brands were noted, along with e-commerce expansion. Management updated 2026 and 2027 outlooks, emphasizing debt reduction and operational improvements. Q3 results included a $4.5M one-time tariff benefit.

finance.yahoo.com